LAKE ZURICH, Illinois -
Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has signed a five-year exclusive worldwide agreement with Verax Biomedical Incorporated to market, sell and distribute Verax’s unique PanGenera(R) Detection (PGD) technology, a rapid diagnostic test used to detect bacterial contaminants in donated blood platelets.
The Verax PGD(R) test is the only rapid test for the detection of bacteria cleared by the United States Food and Drug Administration (FDA) and CE Marked in Europe. Development is underway to apply the Verax PGD(R) technology to detect bacteria in other blood components, tissues for transplantation and cell-based therapies.
The Verax PGD(R) test, based on proprietary technology developed by Verax, consists of an easy-to-use disposable handheld device and reagents that work together to detect the presence of bacterial contaminants in platelets. The test can be performed in fewer than 30 minutes and is designed for use in hospitals, cancer centers and other sites of care as a safeguard immediately prior to transfusion.
More than 5 million platelet doses are transfused annually worldwide. Platelets are tiny cells in blood that help blood clot. They are transfused when platelets levels are low - as, for example, a result of illness or the side effect of some chemotherapy treatments.
An estimated one in 2,000 to 3,000 platelet units may contain bacteria, and up to 50 percent of bacteria-contaminated platelets may escape detection by conventional culture testing, according to experts.(i) Bacteria can cause fatal reactions, especially in immune-compromised patients. The Verax PGD(R) test, a rapid immunoassay, targets antigens found on the surface of a wide spectrum of common bacteria known to be pathogenic to humans in high concentrations.
“Bacterial contamination in platelets is a serious concern in transfusion medicine,” said Darrell J. Triulzi, M.D., medical director of the Institute for Transfusion Medicine and the University of Pittsburgh Medical Center’s Division of Transfusion Medicine, which is using the Verax PGD(R) test. “The blood center community has made progress with the implementation of culture-based tests, but these occur at the point of collection when bacteria levels can be too low for detection. A rapid, point-of-care assay, such as the Verax PGD(R) test, takes place just prior to transfusion, which is the best time to detect bacteria levels in platelets and provides a more comprehensive strategy for patient safety.”
“Transfusion safety is central to the mission of Fenwal and our customers,” said Ron K. Labrum, Fenwal president and chief executive officer. “This agreement is another example of how Fenwal is bringing advanced technology, ideas and performance to our vital industry.”
“Fenwal is a pioneer in the development of products that improve blood safety worldwide,” said Jim Lousararian, Verax president and chief executive officer. “We are confident that with Fenwal’s support we can increase adoption of the Verax PGD(R) test and improve health-care outcomes by reducing transfusion-related issues associated with bacterial contamination.”
About Verax Biomedical
Verax Biomedical Inc. is a leading developer of rapid tests for detecting bacterial contaminants in blood cells and tissue. The privately held company was founded in 1999. Its headquarters and laboratory facilities are in Worcester, Massachusetts. The Verax PGD(R) test is currently cleared by the FDA as a rapid, qualitative immunoassay for the detection of bacteria in leukocyte-reduced apheresis platelets as an adjunct quality-control test following previous bacterial testing. For more information, visit www.veraxbiomedical.com.
About Fenwal
Fenwal Inc. is a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, disposable container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components. Today, the company’s products and advanced collection and separation technologies are used throughout the world to help ensure a safe and available supply of lifesaving blood and blood products. Fenwal Inc. is based in Lake Zurich, Illinois. For more information, please visit www.fenwalinc.com.
(i.) Benjamin R. and Wagner S. The residual risk of sepsis: modeling the effect of concentration on bacterial detection in 2-bottle culture systems and estimation of false-negative culture rates. Transfusion 2007; 47:1381-1389.
Source: Fenwal Inc.
Geoffrey Fenton of Fenwal Inc., +1-847-550-2321, geoffrey.fenton at fenwalinc.com
Related Press Releases
Accredited Construct Specific PCR Test for Recently Detected Unapproved GM Flax/Linseed FP967/CDC Triffid Available Through Genetic IDSeptember 21st, 2009 AUGSBURG, Germany - Subsequent to the announcement of the EU Rapid Alert System for Food and Feed on 8 September 2009, the German surveillance lab in the state of Baden-Wurttemberg has confirmed the detection of GM linseed/flax variety FP967/CDC Triffid, which is unapproved in the EU. Additionally, there have been additional EU Rapid Alert announcements regarding the presence of FP967/CDC Triffid in food products distributed to Germany, Italy, Luxembourg, Netherlands, Belgium, and Switzerland.
Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion TechnologiesAugust 11th, 2009 HONG KONG and LAKE ZURICH, Illinois -
Fenwal, Inc. of Lake Zurich, Illinois, and Golden Meditech (stock code: 801.HK) of Hong Kong, announced today they have agreed to form a joint venture in China to focus on blood collection and transfusion products for the fast-growing Chinese medical market.
Can Bacteria be Good for Your Dog?July 7th, 2009 GENEVA - Your dog's intestinal tract contains 65% of his immune system and contains both good and bad bacteria, the balance which is central to his health and well being. We are all aware of bacteria that cause illness but equally there are bacteria that can actually be good for your dog.
THIS IS A TEST FROM PR NEWSWIRE 5June 5th, 2009 LIVERPOOL, England - THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1
THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 4
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 5
Test Complete
Source: PRN Test CompanyContact: PRN Test
THIS IS A TEST FROM PR NEWSWIRE 4June 5th, 2009 LIVERPOOL, England - THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1
THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 4
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 5
Test Complete
Source: PRN Test CompanyContact: PRN Test
THIS IS A TEST FROM PR NEWSWIRE 3June 5th, 2009 LIVERPOOL, England - THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1
THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 4
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 5
Test Complete
Source: PRN Test CompanyContact: PRN Test
THIS IS A TEST FROM PR NEWSWIRE 2June 5th, 2009 LIVERPOOL, England - THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 1
THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2 THIS IS A TEST THIS IS A TEST THIS IS A TEST THIS IS A TEST Para 2
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3 THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 3
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 4
THIS IS STILL A TEST THISI IS STILL A TEST THIS IS STILL A TEST Para 5
Test Complete
Source: PRN Test CompanyContact: PRN Test
Sirius Genomics Announces New Collaboration with Vanderbilt UniversityMay 6th, 2009 VANCOUVER - Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that it has signed a collaborative agreement with Vanderbilt University to study patients enrolled in Vanderbilt's Validating Acute Lung Injury biomarkers for Diagnosis (VALID) study. The agreement focuses on the continued development of Sirius' pharmacogenomic diagnostic.
Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company OctapharmaApril 30th, 2009 LACHEN, Switzerland - Company Working With Authorities to Ensure Adequate Supply of Virally Inactivated Plasma Derivatives
The impending influenza pandemic will have implications for global stocks of life-saving blood and blood products, warns Swiss-based global biopharmaceutical company, Octapharma. But it has reiterated the safety of its plasma derivatives and is working closely with health authorities and plasma suppliers to maintain the safety profile and continuous supply of its lifesaving products.
Waters and University of Warwick Sign Research Agreement Designed to Foster Adoption of Novel MS TechnologiesApril 15th, 2009 MILFORD, Massachusetts - Centerpiece of the is the establishment of The Waters Centre for BioMedical Mass Spectrometry
Waters Corporation (NYSE: WAT) and the University of Warwick, Coventry and Warwickshire, England, today signed a collaborative research agreement intended to support the growth, development and adoption of novel mass spectrometry (MS) technologies, including Waters(R) SYNAPT High Definition MS(TM) (HDMS(TM)) system. This agreement paves the way for research projects leading to meaningful impact for analysts using biomedical mass spectrometry, validated by peer-reviewed publications, presentations at international conferences and an outreach education program.
Related News
Simple chlamydia urine test offers rapid, pain-free diagnosisJuly 29th, 2009 LONDON - Researchers have developed a new urine test which will allow doctors to diagnose Chlamydia infection in men within the hour, improving the ability to successfully treat the infection on the spot and prevent re-transmission. Chlamydia is caused by the bacterium Chlamydia trachomatis.
Is your mouth clean enough to kiss your girlfriend?May 19th, 2009 WASHINGTON - Whether you're about to kiss your girlfriend or begin a job interview, how would you know whether your breath is sweet and clean. Tel Aviv University (TAU) researchers have come up with a tiny breath test which lets you know whether malodorous bacteria are swarming all over your mouth.
Light-activated antibacterial coating may help fight hospital-acquired infectionsMarch 31st, 2009 WASHINGTON - Scientists at the UCL Eastman Dental Institute have developed a new tool to combat hospital-acquired infections- antibacterial coating that is activated by light. The research team, led by Zoie Aiken, have tested the new coating with antibacterial properties, and found that it could kill 99.9 percent of Escherichia coli bacteria when a white hospital light was shone on its surface to activate it.
Wisconsin lawmakers approve safety alarms for day-care vehicles weeks after baby dies in vanApril 29th, 2009 Wis. lawmakers approve day-care vehicle alarmsMADISON, Wis. — Wisconsin legislators have voted to require day-care providers to install alarm systems in their vehicles to make sure drivers don't leave children behind.
Chemists develop first accurate test for arsenic in soilApril 5th, 2009 WASHINGTON - Analytical chemists have developed the first accurate test for arsenic compounds in soil, providing improved environmental and health impact assessment, and for detecting high arsenic levels in some Asian rice supplies. The test was conducted by analytical chemist Julian Tyson and colleagues at the University of Massachusetts Amherst in the US.
Increase in manufacturing a sign of improving economy: ObamaSeptember 1st, 2009 WASHINGTON - US President Barack Obama Tuesday said a report released showing that manufacturing is on the rise is a sign that the economy is improving. "The steps we are taking to bring our economy back from the brink are working," Obama said.
Novel TB test may provide results quickly, efficientlyMay 8th, 2009 WASHINGTON - A scientist has developed a new diagnostic test for TB, called Xpert MTB/RIF, which can provide results quickly and efficiently. The test, developed by Dr.
Bengals planning to sign former Cowboys safety Roy WilliamsMay 8th, 2009 Bengals planning to sign S Roy WilliamsCINCINNATI — The Bengals expect to sign former Cowboys safety Roy Williams, reuniting him with former defensive coordinator Mike Zimmer. Williams will be in Cincinnati on Thursday to meet with the team and have a physical.
Obama to urge Congress that a 'season for action' on health care has arrivedSeptember 9th, 2009 Obama to urge Congress for action on health careWASHINGTON — President Barack Obama summoned Congress to join in a "season for action" on health care Wednesday night, urging lawmakers to set aside partisan gamesmanship in favor of drafting legislation that benefits millions who have insurance and many more without it. "I am not the first president to take up this cause, but I am determined to be the last," Obama said in excerpts released by the White House in advance of a speech to a joint session of Congress and a public grown increasingly skeptical of his plans.
Foreign carriers may soon buy stake in Indian airlinesJanuary 6th, 2009 NEW DELHI - Foreign airlines may soon be allowed to buy equity stake in domestic carriers, a senior government official said here Wednesday. 'We are in talks with the industry stakeholders.